DEC 27, 2019 8:47 AM PST

New Drug to Treat Migraines Approved by FDA

WRITTEN BY: Annie Lennon

Over 1 in 10 people around the world- or 780 million people. Three times more common in women than in men, until now, most treatments have been preventative, with other regular treatments for headaches usually proving ineffective. This may soon change however, as the Food and Drug Administration (FDA) has just approved a new drug, called Ubrelvy, to address these pains as they happen. 

Dr Billy Dunn, from the FDA’s Center for Drug Evaluation and Research said, “Migraine is an often disabling condition that affects an estimated 37 million people in the US. Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication.”

When common painkillers such as ibuprofen and aspirin fail to treat migraines, the most common treatment option is a class of drugs known as triptans. They work by constricting blood vessels in the brain to stop the feeling of pain. Although effective, they are not considered the safest treatment option, especially for people at risk of cardiovascular disease or stroke. 

Ubrelvy however, works differently. Rather than constricting blood vessels, it targets a protein known as calcitonin gene-related peptide (CGRP) involved in the transmission of pain. As levels of CGRP rise when one has a migraine, by blocking its production, the drug is able to reduce pain therefrom. Although less effective than triptans, this makes it a safer treatment option for those with heart conditions. 

In a randomized, double-blind, placebo-controlled study, the drug was tested at two doses: 25mg and 50mg. At the end of their study, the researchers found that the lower dose left 20.7% of patients pain-free after just two hours alongside 34.1% relieved of most negative symptoms. Meanwhile, 21.8% of those on the higher dosage became pain-free after 2 hours of taking the drug, while 38.9% saw significant reduction in negative symptoms. These figures compare to just 12% of those on the placebo being completely relieved from pain, and 28% seeing a reduction in negative symptoms. 

Showing that Ubrelvy is an effective treatment, the researchers also found that nausea, sleepiness and dry mouth were the most common side effects of the treatment. 


Sources: Interesting Engineering, CNN Health and Slash Gear

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 19, 2020
Drug Discovery & Development
Novel Drug Delivery System for Neurological Diseases
SEP 19, 2020
Novel Drug Delivery System for Neurological Diseases
Scientists at Rutgers have developed a smart drug delivery system that targets inflammation in damaged nerves and helps ...
OCT 01, 2020
Drug Discovery & Development
Antidepressants Treats Lazy Eye
OCT 01, 2020
Antidepressants Treats Lazy Eye
A study published in Current Biology revealed how a therapeutic used as an antidepressant and for managing pain could tr ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 12, 2020
Technology
The Crossover of Virtual Reality and Drug Discovery
NOV 12, 2020
The Crossover of Virtual Reality and Drug Discovery
Researchers have recently developed a unique virtual reality (VR) tool that can help in drug development? Particularly, ...
Loading Comments...